In the initial phases of the disease, the accumulation of immature myeloid cells (myeloid-derived suppressor cells, MDSCs), which originate from the malignant BCR-ABL1 clone, leads to suppression of the innate and adaptive immune system, leading to CML development. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.